Backbone vector plasmid of lentivirus construct driven by EF-1 alpha promoter with hKO1 fluorescent protein marker.
Clone info. | Backbone vector plasmid of lentivirus construct driven by EF-1 alpha promoter with hKO1 fluorescent protein marker. |
---|---|
Comment | Commonly requested with pCMV-VSV-G-RSV-Rev (RDB04393) and pCAG-HIVgp (RDB04394). |
Vector backbone | CSII-EF-MCS (RDB04378) () |
Selectable markers | Ampicillin (E. coli). Please note that Zeo resistance marker is not included in the lentivirus produced from this vector. |
Depositor|Developer | Miyoshi, Hiroyuki | |
Sequence (full) | RDB07915zzk02.seq provided by the depositor | Remarks, protocol and/or map (pdf) | RDB07915.pdf |
---|
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms | Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ] MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ] Please visit Ordering instruction.[link] |
---|---|
Terms and conditions for distribution | The availability of the BIOLOGICAL RESOURCE is limited to a RECIPIENT of a not-for profit institution for a not-for-profit academic purpose. The RECIPIENT agrees to expressly describe the late Dr. Hiroyuki Miyoshi as the Developer. Additional terms and conditions: When publishing the results obtained using the BIOLOGICAL RESOURCE, a citation of literature specified by Dr. Atsushi Miyawaki or an acknowledgement to Dr. Miyawaki is requested. Karasawa, S. et al., Biochem. J. 381: 307-312 (2004). |
Remarks | ((Remarks)) Remember that you will be working with samples containing infectious virus. Please contact us. We will provide you with appropriate documents. |
必要書類 | 提供依頼書 [依頼書の記入例 ] 提供同意書 (MTA, 非営利学術目的用)[Word] [MTAの記入例 ] 遺伝子組換え生物の受入れ確認書が必要です。当室にご請求ください。 手続きの概要は、「レンチウイルスベクターの提供申し込み」をご覧ください。 |
---|---|
MTAに書く使用条件 | 本件研究材料は、非営利機関の非営利学術研究に限って提供する。本件研究材料を利用した研究結果等を発表する際は、本件研究材料が故三好浩之博士により開発されたことを明示する。 付加的使用条件: When publishing the results obtained using the BIOLOGICAL RESOURCE, a citation of literature specified by Dr. Atsushi Miyawaki or an acknowledgement to Dr. Miyawaki is requested. Karasawa, S. et al., Biochem. J. 381: 307-312 (2004). |
備考 | 【使用上の注意】このリソースはウイルス粒子産生用のため、取扱いに注意が必要です。 |
Catalog # | Resource name | Shipping form | Fee (non-profit org.) |
---|---|---|---|
RDB07915 | CSII-EF-MCS-IRES2-hKO1 | DNA solution |
Materials & Methods section:
The CSII-EF-MCS-IRES2-hKO1 was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB07915). |
Reference section:
Further references such as user reports and related articles (go to bottom)
RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.
Test sheet | RDB16940_A9Cip1-2.pdf |
---|
Nucleotide sequence of a portion of this resource (if available).
Primer: EF1a-C_F (Pr0168) Region: EF-1 alpha pro, IRES2 Sequence file: RDB16940_A9Cig.seq |
---|
>07915_16940_A9Ci_3_EF1a-C_F_A03_03_ABI24.ab1 1 NNNNNNNNNN NNNTTTTGAN TTTGGNNCTT GGTTCNTTCT CNAGCCTCAG ACAGTGGTTC 61 AAAGTTTTTT TCTTCCNTTT CAGGTGTCGT GAACACGCTA CCGGTCTCGA GAATTCTGCA 121 GCGGCCGCGG ATCCGCCCCT CTCCCTCCCC CCCCCCTAAC GTTACTGGCC GAAGCCGCTT 181 GGAATAAGGC CGGTGTGCGT TTGTCTATAT GTTATTTTCC ACCATATTGC CGTCTTTTGG 241 CAATGTGAGG GCCCGGAAAC CTGGCCCTGT CTTCTTGACG AGCATTCCTA GGGGTCTTTC 301 CCCTCTCGCC AAAGGAATGC AAGGTCTGTT GAATGTCGTG AAGGAAGCAG TTCCTCTGGA 361 AGCTTCTTGA AGACAAACAA CGTCTGTAGC GACCCTTTGC AGGCAGCGGA ACCCCCCACC 421 TGGCGACAGG TGCCTCTGCG GCCAAAAGCC ACGTGTATAA GATACACCTG CAAAGGCGGC 481 ACAACCCCAG TGCCACGTTG TGAGTTGGAT AGTTGTGGAA AGAGTCAAAT GGCTCTCCTC 541 AAGCGTATTC AACAAGGGGC TGAAGGATGC CCAGAAGGTA CCCCATTGTA TGGGATCTGA 601 TCTGGGGCCT CGGTNCACAT GCTTTACATG TGTTTAGTCG AGGTTAAAAA AACGTCTAGG 661 CCCCCCGAAC CACNGGGANG TGGTTTTCCT TTNAAAAACA CGATGNTAAT ATGGCCACGG 721 GGNTNCCCAC CATGGTGAGC GTGNTCAAGC CCGANATGAA GATGAAGTAC TTCNTNGNNG 781 GNANCGTNNN CGGNNNCNAN TTNNNCGTGG ANGNNGAGGG CACCNGNNNA NCCCTNCNAN 841 GGNNNCCNNN ANNTGANCCT NANGNNNANA NTNGNNNNAG GGCNGNCCCN NNCCNTTNNN 901 CNNNNNNNTN NNNNNNCNCN NNTTNNNNTN NNNNNNNNN // |
Primer: PRE_rev (Pr0250) Region: PRE, hKO, IRES2 Sequence file: RDB16940_A9Cih.seq |
>07915_16940_A9Ci_3_PRE_rev_B10_04_ABI24.ab1 1 NNNNNNNNNN NNNNNGNNNN NNNNCNNCAT AGTTAAGAAN ACCAGTCAAT CTTTCNCAAA 61 TTTTGTAATC CAGAGGTTGA TTATCGATAA GCTTGATCCC TCGATGTTAA CTCTAGCCTG 121 CAGTCAGCAG TGGGCCACGG CGTCCTCCAC CAGCTCGGTG ATGTTGCCCT CGGTCTTCCT 181 CACCAGCCTG TGGCCGATGA AGTGGCTCTG GGGCATCTTC AGGATCTTCT TGGCGGCCTT 241 GTAGGTGGTC TTGAACTGGC ACTTGTGGTT GCCGCCGCCG GCCAGCTTCA GGTACATGGT 301 CACGTCGCCC TTCAGCACGC CGTCGCAGGT GGTGATCTTC TCGGTGCTGG GCTCCCAGTC 361 GCTGCTCTGG TTCTGCATCA CGGGGCCGTC GGCGGGGAAG TTCACGCCCA CGAACTTGCT 421 CTTGTGCTCG AAGCAGTTGC CCCTCAGGCT GATGTGGGCG CTCACGGCGG CGAAGCCGCC 481 GTCCTCGAAC TGGAGGCTCC TCTCCCAGCT CAGGCCCTCG GGGAAGGCCT GCTTGAAGTA 541 GTCGGGGATC TCCTCGGGGT ACTTGGTGAA GGGCCTGTGG CCGTAGCAGA AGGTGTGGCT 601 CACCAGGTCG AAGCTGAAGG GCATGGGGCC GCCCTTGGCC ATTGTCACCC TCAGGGTCAT 661 CTCCTGGTGG CCCTCGTAGG GCTTGCCGGT GCCCTCGCCC TCCACGGTGA ACTCGTGGCC 721 GTTCACGCTG CCGTCCATGA AGTACTTCAT CTTCATCTCG GGCTTGATCA CGCTCACCAT 781 GGTGGGGATC CCCGTGGCCA TATTATCATC GTGTTTTTCA AANGAAAACC ACGTCCCCNN 841 GGTTCGGGGG GGNCTANANG TTTTTTTAAC CTCNANTAAN CACATGTAAA GCATGTGTAN 901 CNANGCCCCA NNTCANATNC NNTACAANGG GGGTNNNNTC TGGNNATCCT TCANCCCNNT 961 NNNTGAATAN NCNTNNANNA NNNCNNTTTG NNNNTTNNNN NNNNNN // |
Primer: IRES-F (Pr0036) Region: IRES2, hKO 5' Sequence file: RDB16940_A9Cii.seq |
>07915_16940_A9Ci_3_IRES-F_F10_16_ABI24.ab1 1 NNNNNNNNNN NNNNNNTNNG TCGANGTTNN NAAACGTCTA GGCCCCCCGA ACCACGGGGN 61 CGTGGTTTTC CTTTGAAAAA CACGATGATA ATATGGCCAC GGGGATCCCC ACCATGGTGA 121 GCGTGATCAA GCCCGAGATG AAGATGAAGT ACTTCATGGA CGGCAGCGTG AACGGCCACG 181 AGTTCACCGT GGAGGGCGAG GGCACCGGCA AGCCCTACGA GGGCCACCAG GAGATGACCC 241 TGAGGGTGAC AATGGCCAAG GGCGGCCCCA TGCCCTTCAG CTTCGACCTG GTGAGCCACA 301 CCTTCTGCTA CGGCCACAGG CCCTTCACCA AGTACCCCGA GGAGATCCCC GACTACTTCA 361 AGCAGGCCTT CCCCGAGGGC CTGAGCTGGG AGAGGAGCCT CCAGTTCGAG GACGGCGGCT 421 TCGCCGCCGT GAGCGCCCAC ATCAGCCTGA GGGGCAACTG CTTCGAGCAC AAGAGCAAGT 481 TCGTGGGCGT GAACTTCCCC GCCGACGGCC CCGTGATGCA GAACCAGAGC AGCGACTGGG 541 AGCCCAGCAC CGAGAAGATC ACCACCTGCG ACGGCGTGCT GAAGGGCGAC GTGACCATGT 601 ACCTGAAGCT GGCCGGCGGC GGCAACCACA AGTGCCAGTT CAAGACCACC TACAAGGCCG 661 CCAAGAAGAT CCTGAAGANG CCCCAGAGCC ACTTCATCGG CCACAGGCTG GTGAGGAAGA 721 NCGANGGCAA CATCACCGAN CTGGTGGAGG ACGCCGTGGC CCACTGCTGA CTGCAGGCTA 781 GAGTTAACAT CGAGGGATCN AGCTTATCGA TNATCAACCT CTGGNNTACN AAATTTGTGA 841 AAGANTGACT GGNATTCTNA ACTATGTTGC TCCNTTTACG CTATGNNGNN ACGCTGCTTN 901 NANGNCTTTG NATCATGCTA TNGNNNCCCG TANNNNTTNN ATTTTNNNNN NNCNTNNNAN 961 ANNNCNNNNN NNNNN // |
Primer: CMV_Forward (Pr0016) Region: CMV pro, 5' LTR, HIV-1 psi Sequence file: RDB16940_A9Cij.seq |
>07915_16940_A9Ci_3_CMV-Forward_C10_07_ABI24.ab1 1 NNNNNNNNNN NNNNTTGNNG CNNTGGGCGG TAGGCGTGTN CGGTGGGAGG TCTATATAAG 61 CAGCGCGTTT TGCCTGTACT GGGTCTCTCT GGTTAGACCA GATCTGAGCC TGGGAGCTCT 121 CTGGCTAACT AGGGAACCCA CTGCTTAAGC CTCAATAAAG CTTGCCTTGA GTGCTTCAAG 181 TAGTGTGTGC CCGTCTGTTG TGTGACTCTG GTAACTAGAG ATCCCTCAGA CCCTTTTAGT 241 CAGTGTGGAA AATCTCTAGC AGTGGCGCCC GAACAGGGAC TTGAAAGCGA AAGGGAAACC 301 AGAGGAGCTC TCTCGACGCA GGACTCGGCT TGCTGAAGCG CGCACGGCAA GAGGCGAGGG 361 GCGGCGACTG GTGAGTACGC CAAAAATTTT GACTAGCGGA GGCTAGAAGG AGAGAGATGG 421 GTGCGAGAGC GTCAGTATTA AGCGGGGGAG AATTAGATCG CGATGGGAAA AAATTCGGTT 481 AAGGCCAGGG GGAAAGAAAA AATATAAATT AAAACATATA GTATGGGCAA GCAGGGAGCT 541 AGAACGATTC GCAGTTAATC CTGGCCTGTT AGAAACATCA GAAGGCTGTA GACAAATACT 601 GGGACAGCTA CAACCATCCC TTCAGACAGG ATCAGAAGAA CTTAGATCAT TATATAATAC 661 AGTAGCAACC CTCTATTGTG TGCATCAAAG GATAGAGATA AAAGACACCA AGGAAGCTTT 721 AGACAAGATA GAGGAAGAGC AAAACAAAAG TAAGACCACC GCACAGCAAG GGCCGCTGAT 781 CTTCAGANCT GGNNGANGAN ATATGAGGGA NAATTGGAGA AGTGAATTAT ATAAATATNA 841 AGTAGTAAAA ATTGAACCNT TANGANNAGC NCCCACNNNG GNNAAGANAA NNNNNGNNGN 901 ANANNNNAAA AAAGANCANN NGGNANTNNG NNNNNTNNNT NNNNNNGGNN TNNNTNNGNN 961 NNNNNNNN // |
Primer: EF1a-N_R (Pr0024) Region: EF-1 alpha pro, cPPT_CTS Sequence file: RDB16940_A9Cik.seq |
>07915_16940_A9Ci_3_EF1a-N_R_B03_06_ABI24.ab1 1 NNNNNNNNNN NNNNGGNGNN GTGCGCTCTG CCCNCTGNCG GGCACCGGAN CCTCACGAAG 61 CTTGAATTAA TTCAAAGTGA ATTTCTGCTG TCCCTGTAAT AAACCCGAAA ATTTTGAATT 121 TTTGTAATTT GTTTTTGTAA TTCTTTAGTT TGTATGTCTG TTGCTATTAT GTCTACTATT 181 CTTTCCCCTG CACTGTACCC CCCAATCCCC CCTTTTCTTT TAAAATTGTG GATGAATACT 241 GCCATTTGTA GATCCGTTCA CTAATCGAAT GGATCTGTCT CTGTCTCTCT CTCCACCTTC 301 TTCTTCTATT CCTTCGGGCC TGTCGGGTCC CCTCGGGGTT GGGAGGTGGG TCTGAAACGA 361 TAATGGTGAA TATCCCTGCC TAACTCTATT CACTATAGAA AGTACAGCAA AAACTATTCT 421 TAAACCTACC AAGCCTCCTA CTATCATTAT GAATAATTTT ATATACCACA GCCAATTTGT 481 TATGTTAAAC CAATTCCACA AACTTGCCCA TTTATCTAAT TCCAATAATT CTTGTTCATT 541 CTTTTCTTGC TGGTTTTGCG ATTCTTCAAT TAAGGAGTGT ATTAAGCTTG TGTAATTGTT 601 AATTTCTCTG TCCCACTCCA TCCAGGTCGT GTGATTCCAA ATCTGTTCCA GAGATTTATT 661 ACTCCAACTA GCATTCCAAG GCACAGCAGT GGTGCAAATG AGTTTTCCAG AGCAACCNCN 721 AATCCCCAGG AGCTGTTGAT CCTTTAGGTA TCTTTCCACA GCCAGGATTC TTGCCTGGAG 781 CTGCTTGATG CCCCAGACTG TGANTTGCAA CAGATGCTGT TGCGCCTCAA TAGCCCTCAN 841 NAANNNGNTC TGCTGCTGCA CTATACCAGA NAATAATTGT CTGGNCTGTA CCNNCAGCGN 901 CNTTNACNCN NCGCCCATAN NGCTTNCNGN NNCTNNNNNN ANCCCAANNN NNNAAANNTN 961 NNNNTNCCCN CTGCNNNTTT NNNNNNNNNN // |
Primer: BGH_rev2 (Pr0606) Region: bGH pA, 3' LTR Sequence file: RDB16940_A9Cil.seq |
>07915_16940_A9Ci_3_BGH_rev2_D10_10_ABI24.ab1 1 NNNNNNNNNN NNNNNNNNGG GGGNNGGNNN NNNACNGATG GCTGGCAACT AGAAGGCACA 61 GTCGAGGCTG ATCAGCGGGT TTAAACGGGC CCTGCTAGAG ATTTTCCACA CTGACTAAAA 121 GGGTCTGAGG GATCTCTAGT TACCAGAGTC ACACAACAGA CGGGCACACA CTACTTGAAG 181 CACTCAAGGC AAGCTTTATT GAGGCTTAAG CAGTGGGTTC CCTAGTTAGC CAGAGAGCTC 241 CCAGGCTCAG ATCTGGTCTA ACCAGAGAGA CCCAGTACAG TCCGGATGCA GCTCTCGGGC 301 CATGTGATGA AATGCTAGGC GGCTGTCAAA CCTCCACTCT AATACTTCTC TCTCCGGGTC 361 ATCCATCCCA TGCAGGCTCA CAGGGTGTAA CAAGCGGGTG TTCTCTCCTT CATTGGCTTC 421 TTCTACCTTC TCTTGCTCAA CTGGTACTAG CTTGTAGCAC CATCCAAAGG TCAGTGGATA 481 TCTGATCCCT GGCCCTGGTG TGTAGTTCTG CCAATCAGGG AAGTAGCCTT GTGTGTGGTA 541 GATCCACAGA TCAAGGATAT CTTGTCTTCG TTGGGAGTGA ATTAGCCCTT CCAGTCCCCC 601 CTTTTCTTTT AAAAAGTGGC TAAGATCTAC AGCTGCCTTG TAAGTCATTG GTCTTAAAGG 661 TACCTGAGGT GTGACTGGAA AACCCACCTC CTCCTCCTCT TGTGCTTCTA GCCAGGCACA 721 ATCAGCATTG GTAGCTGCTG TATTGCTACT TGTGATTGCT CCATGTTTTT CTAGGTCTCG 781 ACNGTATCGA TGCGGGGANG CGGCCCNAAG GGAGATCCGA CTCGTCTGAN GGCGANNNNG 841 AAGANGCGGA AGANGNNGCA NANCCNNNNN CNNNNCNCNG GAAGGAAGGN CCGCTGGATT 901 GANGGNCNNA NNGNANNNNN CNNAANGNNN TCCCGCNCAN AANNNNNNGN NGNNNNNNCN 961 NNNNNNNNN // |
Primer: SV40pro_F (Pr0110) Region: SV40 pro_ori, EM7 pro, Zeo, SV40 pA Sequence file: RDB16940_A9Cim.seq |
>07915_16940_A9Ci_3_SV40pro_F_G10_19_ABI24.ab1 1 NNNNNNNNNN NNNNNNNNAN NNGTGNNGNN GNTTTTTTGG ANGCCTAGGC TTTTGCAAAA 61 AGCTCCCGGG AGCTTGTATA TCCATTTTCG GATCTGATCA GCACGTGTTG ACAATTAATC 121 ATCGGCATAG TATATCGGCA TAGTATAATA CGACAAGGTG AGGAACTAAA CCATGGCCAA 181 GTTGACCAGT GCCGTTCCGG TGCTCACCGC GCGCGACGTC GCCGGAGCGG TCGAGTTCTG 241 GACCGACCGG CTCGGGTTCT CCCGGGACTT CGTGGAGGAC GACTTCGCCG GTGTGGTCCG 301 GGACGACGTG ACCCTGTTCA TCAGCGCGGT CCAGGACCAG GTGGTGCCGG ACAACACCCT 361 GGCCTGGGTG TGGGTGCGCG GCCTGGACGA GCTGTACGCC GAGTGGTCGG AGGTCGTGTC 421 CACGAACTTC CGGGACGCCT CCGGGCCGGC CATGACCGAG ATCGGCGAGC AGCCGTGGGG 481 GCGGGAGTTC GCCCTGCGCG ACCCGGCCGG CAACTGCGTG CACTTCGTGG CCGAGGAGCA 541 GGACTGACAC GTGCTACGAG ATTTCGATTC CACCGCCGCC TTCTATGAAA GGTTGGGCTT 601 CGGAATCGTT TTCCGGGACG CCGGCTGGAT GATCCTCCAG CGCGGGGATC TCATGCTGGA 661 GTTCTTCGCC CACCCCAACT TGTTTATTGC AGCTTATAAT GGTTACAAAT AAAGCAATAG 721 CATCACAAAT TTCACNAATA AAGCATTTTT TTCACTGCAT TCTANNNGTG GTTTGTCCNA 781 ACTCATCAAT GTATCTTATC ATGTCTGTAT ACCGTCNACC TCTAGCTAGA GCTTGNCGTA 841 NTCATGGTCA TAGCNGNTTN CNTGTGTGAA ANTGTTATNC NNCTCACAAT TNCNCACNAN 901 CATACGANCC NGGANNCATA AAGTGTAAAN CCNGGGGGTG NCNNANNNNT GNNCTANNNN 961 NCNTTNANTN GNNTTGCNCN NNNNNNNNN // |
Please visit Sequencing and PCR primers for primer information.
Original, user report and related articles
user_report | Nakao, F., Targeting a mitochondrial E3 ubiquitin ligase complex to overcome AML cell-intrinsic Venetoclax resistance. Leukemia 37 (5): 1028-1038 (2023). PMID 36973350. [link to RRC of NBRP] |
---|---|
user_report | Takeuchi, K., Incorporation of human iPSC-derived stromal cells creates a pancreatic cancer organoid with heterogeneous cancer-associated fibroblasts. Cell Rep. 42 (11): 113420 (2023). PMID 37955987. [link to RRC of NBRP] |
user_report | Morita, K., Allosteric Activators of Protein Phosphatase 2A Display Broad Antitumor Activity Mediated by Dephosphorylation of MYBL2. Cell 181 (3): 702-715.e20 (2020). PMID 32315619. [link to RRC of NBRP] |
user_report | Morita, K., Genetic regulation of the RUNX transcription factor family has antitumor effects. J. Clin. Invest. 127 (7): 2815-2828 (2017). PMID 28530640. [link to RRC of NBRP] |
user_report | Morita, K., Autonomous feedback loop of RUNX1-p53-CBFB in acute myeloid leukemia cells. Sci. Rep. 7 (1): 16604 (2017). PMID 29192243. [link to RRC of NBRP] |
user_report | Morita, K., Paradoxical enhancement of leukemogenesis in acute myeloid leukemia with moderately attenuated RUNX1 expressions. Blood Adv. 1: 1440-1451 (2017). PMID 29296785. [link to RRC of NBRP] |
user_report | Lee, J., Genetic reconstruction of mouse spermatogonial stem cell self-renewal in vitro by Ras-cyclin D2 activation. Cell Stem. Cell, 5, 76-86 (2009). PMID 19570516. [link to RRC of NBRP] |
Featured content